NAKA
Nakamoto Inc.NASDAQHealthcare$0.22+0.32%ClosedMarket Cap: $82.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.09
P/S
45.16
EV/EBITDA
-5.99
DCF Value
$-1.21
FCF Yield
-33.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
-508.8%
Operating Margin
-1160.1%
Net Margin
-2867.6%
ROE
-20.8%
ROA
-7.1%
ROIC
-2.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $444.9K | -2388.2% | $-7.3M | $37.3M | $0.68 | — |
| FY 2025 | $1.8M | -508.8% | $-21.1M | $-52.2M | $-0.26 | — |
| Q3 2025 | $388.2K | 99.5% | $-10.4M | $-86.0M | $-0.42 | — |
| Q2 2025 | $408.5K | 98.2% | $-2.4M | $-2.4M | $-0.35 | — |
| Q1 2025 | $579.7K | 98.6% | $-1.0M | $-1.0M | $-0.17 | — |
| Q4 2024 | $603.9K | 99.1% | $-1.0M | $-1.0M | $-0.17 | — |
| FY 2024 | $2.7M | 97.0% | $-3.3M | $-3.6M | $-0.67 | — |
| Q3 2024 | $647.9K | 98.8% | $-1.0M | $-1.0M | $-0.17 | — |
| Q2 2024 | $639.1K | -94.2% | $-1.0M | $-1.3M | $-0.26 | — |
| Q1 2024 | $829.0K | 7.6% | $-237.1K | $-282.3K | $-0.05 | — |
| Q4 2023 | $759.4K | -14.1% | $-302.1K | $-324.9K | $-0.05 | — |
| FY 2023 | $3.8M | -7.0% | $-1.6M | $-1.6M | $-0.27 | — |